EDTA 300

product on market Tablet or Pill Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium and potassium are essential minerals that support nerve function and electrolyte balance. Research provides strong evidence for their roles in cardiovascular and muscular health. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for EDTA 300
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
60
Servings
Mineral
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

54 mg (13% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Potassium
390 mg (8% DV)

Other Ingredients

Micosolle Cellulose Stearic Acid Silicon Dioxide Potassium Bicarbonate Croscarmellose Sodium Magnesium Stearate Food Glaze Coating
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, 3 tablets with a glass of water two times daily, 30 minutes before breakfast and at bedtime, or as directed by a healthcare professional.

Warnings & Precautions

Caution: This product is recommended to be used under medical supervision in order to evaluate results. EDTA is known to deplete trace minerals, so repletion is suggested. The doctor may also wish to support kidney and liver function.

Keep out of reach of children.

Formulation Notes

EDTA 300 EDTA dipotassium magnesium

A specially formulated dipotassium salt of EDTA magnesium chelate, providing both potassium and magnesium. A daily serving of 6 tablets supplies 1.8 g of EDTA complex, equivalent to 1.3 g of EDTA free acid.

Hypoallergenic

Additional Information

Store in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 77100 0
DSLD Entry Date2021-12-18
Product TypeMineral
FormTablet or Pill
DSLD ID258086
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.